|
|
||||||||
The Journal of Immunology, Vol 155, Issue 8 3742-3749, Copyright © 1995 by American Association of Immunologists
ARTICLES |
C Davenport, V Kumar and M Bennett
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA.
Acute rejection of transplanted bone marrow cell (BMC) grafts can occur within 48 h in unsensitized, lethally irradiated mice, and NK cells have been implicated as the effector cells. Recently, we observed that both CD8+ TCR-alpha beta+ T and NK cells of irradiated mice could rapidly reject allogeneic lymph node cell grafts. In this study, we evaluated the ability of NK and CD8+ T cells to mediate rejection of H2k or H2k/b BMC grafts by pretreating groups of mice with depleting mAbs. H2k BMC were transplanted into syngeneic, B6 (H2b), BALB/c (H2d), NZB (H2d), and (NZB x B6)F1 (NZB6F1, H2d/b) hosts. Proliferation measured 5 days after cell transfer indicated that syngeneic, B6, and BALB/c hosts accepted H2k BMC grafts. However, CD8+ T cells from NZB and poly I:C-treated BALB/c hosts, and NK cells from poly I:C-treated NZB6F1, hosts, rejected H2k BMC grafts. In NZB6F1 hosts, there was an added effect of anti-TCR-alpha beta and anti-NK1.1 mAbs. It is possible that T and NK cells cooperate in rejecting H2k or H2k/b BMC grafts in certain hosts. Transplantation of H2k/b, but not H2k/d, BMC into similar recipients had the same fate as H2k BMC. Thus, certain CD8+ T cells may share a similar recognition system with NK cells.
This article has been cited by other articles:
![]() |
M. H. Johansson, M. A. Taylor, M. Jagodic, K. Tus, J. D. Schatzle, E. K. Wakeland, and M. Bennett Mapping of Quantitative Trait Loci Determining NK Cell-Mediated Resistance to MHC Class I-Deficient Bone Marrow Grafts in Perforin-Deficient Mice J. Immunol., December 1, 2006; 177(11): 7923 - 7929. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Barao, A. M. Hanash, W. Hallett, L. A. Welniak, K. Sun, D. Redelman, B. R. Blazar, R. B. Levy, and W. J. Murphy Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells PNAS, April 4, 2006; 103(14): 5460 - 5465. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Brehm, K. A. Daniels, J. R. Ortaldo, and R. M. Welsh Rapid Conversion of Effector Mechanisms from NK to T Cells during Virus-Induced Lysis of Allogeneic Implants In Vivo J. Immunol., June 1, 2005; 174(11): 6663 - 6671. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Ildstad, P. M. Chilton, H. Xu, M. A. Domenick, and M. B. Ray Preconditioning of NOD mice with anti-CD8 mAb and costimulatory blockade enhances chimerism and tolerance and prevents diabetes, while depletion of {alpha}{beta}-TCR+ and CD4+ cells negates the effect Blood, March 15, 2005; 105(6): 2577 - 2584. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, B. G. Exner, P. M. Chilton, C. Schanie, and S. T. Ildstad CD45 Congenic Bone Marrow Transplantation: Evidence for T Cell-Mediated Immunity Stem Cells, November 1, 2004; 22(6): 1039 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mammolenti, S. Gajavelli, P. Tsoulfas, and R. Levy Absence of Major Histocompatibility Complex Class I on Neural Stem Cells Does Not Permit Natural Killer Cell Killing and Prevents Recognition by Alloreactive Cytotoxic T Lymphocytes In Vitro Stem Cells, November 1, 2004; 22(6): 1101 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Komatsu, M. Mammolenti, M. Jones, R. Jurecic, T. J. Sayers, and R. B. Levy Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing Blood, May 15, 2003; 101(10): 3991 - 3999. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, B. G. Exner, D. E. Cramer, M. K. Tanner, Y. M. Mueller, and S. T. Ildstad CD8+, {alpha}{beta}-TCR+, and {gamma}{delta}-TCR+ Cells in the Recipient Hematopoietic Environment Mediate Resistance to Engraftment of Allogeneic Donor Bone Marrow J. Immunol., February 15, 2002; 168(4): 1636 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, M. A. Morris, P. Nguyen, T. C. George, E. Koulich, W. C. Lai, J. D. Schatzle, V. Kumar, and M. Bennett Ly49I NK Cell Receptor Transgene Inhibition of Rejection of H2b Mouse Bone Marrow Transplants J. Immunol., February 15, 2000; 164(4): 1793 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. George, L. H. Mason, J. R. Ortaldo, V. Kumar, and M. Bennett Positive Recognition of MHC Class I Molecules by the Ly49D Receptor of Murine NK Cells J. Immunol., February 15, 1999; 162(4): 2035 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Fowler, B. Whitfield, M. Livingston, P. Chrobak, and R. E. Gress Non-Host-Reactive Donor CD8+ T Cells of Tc2 Phenotype Potently Inhibit Marrow Graft Rejection Blood, June 1, 1998; 91(11): 4045 - 4050. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |